natgillin/translations-raw huggingface dataset:
Member States which have not adopted the euro as their currency by the date when the irregularity is established shall convert expenditure incurred in national currency into euro. The amount shall be converted into euro by using the Commission’s monthly accounting rate for the month in which the expenditure was or would have been entered into the accounts of the paying authority responsible for the operational programme in question.
Države članice, ki niso sprejele eura kot svoje valute do datuma, ko je nepravilnost ugotovljena, morajo znesek zadevnih izdatkov v nacionalni valuti spremeniti v EUR. Ta znesek se spremeni v EUR z uporabo mesečnega računovodskega menjalnega tečaja Komisije za mesec, v katerem je ali bi plačilni organ, odgovoren za zadevni operativni program, izdatek vknjižil v poslovne knjige.
Commission Regulation (EC) No 2036/2005
Uredba Komisije (ES) št. 2036/2005
concerning the permanent authorisations of certain additives in feedingstuffs and the provisional authorisation of a new use of certain additives already authorised in feedingstuffs
o trajnih dovoljenjih za nekatere dodatke v krmnih mešanicah in začasnem dovoljenju za novo uporabo že dovoljenih dodatkov v krmnih mešanicah
Article 25 of Regulation (EC) No 1831/2003 lays down transitional measures for applications for the authorisation of feed additives submitted in accordance with Directive 70/524/EEC before the date of application of Regulation (EC) No 1831/2003.
Člen 25 Uredbe (ES) št. 1831/2003 določa prehodne ukrepe za zahtevke za dovoljenje za krmne dodatke, predložene v skladu z Direktivo 70/524/EGS pred datumom uporabe Uredbe (ES) št. 1831/2003.
The applications for the authorisation of the additives listed in the Annexes to this Regulation were submitted before the date of application of Regulation (EC) No 1831/2003.
Zahtevki za dovoljenje za dodatke, ki so navedeni v prilogah k tej uredbi, so bili predloženi pred datumom uporabe Uredbe (ES) št. 1831/2003.
Initial comments on those applications, as provided for in Article 4(4) of Directive 70/524/EEC, were forwarded to the Commission before the date of application of Regulation (EC) No 1831/2003.
Prvotne pripombe v zvezi z omenjenimi zahtevki, kot so predvideni v členu 4(4) Direktive 70/524/EGS, so bile posredovane Komisiji pred datumom uporabe Uredbe (ES) št. 1831/2003.
Those applications are therefore to continue to be treated in accordance with Article 4 of Directive 70/524/EEC.
Omenjene zahtevke je zato treba še naprej obravnavati v skladu s členom 4 Direktive 70/524/EGS.
The use of the micro-organism preparation of Saccharomyces cerevisiae (CNCM I-1079) was provisionally authorised, for the first time, for sows by Commission Regulation (EC) No 1436/98 [3].
Uporaba pripravka mikroorganizmov Saccharomyces cerevisiae (CNCM I-1079) je bila z Uredbo Komisije (ES) št. 1436/98 [3] prvič začasno dovoljena za svinje.
New data were submitted in support of an application for authorisation without a time limit of that micro-organism preparation.
V podporo zahtevku za izdajo dovoljenja brez časovne omejitve za navedeni pripravek mikroorganizmov so bili predloženi novi podatki.
Accordingly, the use of that micro-organism preparation, as specified in Annex I, should be authorised without a time limit.
V skladu s tem je treba uporabo navedenega pripravka mikroorganizmov, kot je določen v Prilogi I, dovoliti brez časovne omejitve.
The use of the micro-organism preparation of Pediococcus acidilactici (CNCM MA 18/5M) was provisionally authorised, for the first time, for pigs for fattening by Commission Regulation (EC) No 866/1999 [4].
Uporaba pripravka mikroorganizmov Pediococcus acidilactici (CNCM MA 18/5M) je bila z Uredbo Komisije (ES) št. 866/1999 [4] prvič začasno dovoljena za prašiče za pitanje.
The use of the micro-organism preparation of Enterococcus faecium (CECT 4515) was provisionally authorised, for the first time, for piglets by Commission Regulation (EC) No 654/2000 [5].
Uporaba pripravka mikroorganizmov Enterococcus faecium (CECT 4515) je bila z Uredbo Komisije (ES) št. 654/2000 [5] prvič začasno dovoljena za pujske.
The use of the enzyme preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 526.94) was provisionally authorised for the first time for chickens for fattening by Commission Regulation (EC) No 2374/98 [6].
Uporaba encimskega pripravka endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 526.94), je bila z Uredbo Komisije (ES) št. 2374/98 [6] prvič začasno dovoljena za piščance za pitanje.
New data were submitted in support of an application for authorisation without a time limit of that enzyme preparation.
V podporo zahtevku za izdajo dovoljenja brez časovne omejitve ta navedeni encimski pripravek so bili predloženi novi podatki.
Accordingly, the use of that enzyme preparation, as specified in Annex II, should be authorised without a time limit.
V skladu s tem je treba uporabo navedenega encimskega pripravka, kot je določen v Prilogi II, dovoliti brez časovne omejitve.
The use of the enzyme preparation of endo-1,4-beta-xylanase produced by Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glucanase and alpha-amylase produced by Bacillus amyloliquefaciens (DSM 9553), subtilisin produced by Bacillus subtilis (ATCC 2107) and polygalacturonase produced by Aspergillus aculeatus (CBS 589.94) was provisionally authorised for the first time for chickens for fattening by Commission Regulation (EC) No 418/2001 [7].
Uporaba encimskega pripravka endo-1,4-beta-ksilanaze, ki jo proizvaja Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glukanaze in alfa-amilaze, ki ju proizvaja Bacillus amyloliquefaciens (DSM 9553), subtilizina, ki ga proizvaja Bacillus subtilis (ATCC 2107), in poligalakturonaze, ki jo proizvaja Aspergillus aculeatus (CBS 589.94), je bila z Uredbo Komisije (ES) št. 418/2001 [7] prvič začasno dovoljena za piščance za pitanje.
The use of the enzyme preparation of endo-1,4-beta-xylanase produced by Aspergillus oryzae (DSM 10287) was authorised without a time limit for chickens for fattening, turkeys for fattening and piglets by Commission Regulation (EC) No 1332/2004 [8].
Uporaba encimskega pripravka endo-1,4-beta-ksilanaze, ki jo proizvaja Aspergillus oryzae (DSM 10287), je bila z Uredbo Komisije (ES) št. 1332/2004 [8] dovoljena brez časovne omejitve za piščance za pitanje, purane za pitanje in pujske.
New data were submitted in support of an application to extend the authorisation of the use of this enzyme preparation to ducks and pigs for fattening.
V podporo zahtevku za razširitev dovoljenja za uporabo tega encimskega pripravka na race in prašiče za pitanje so bili predloženi novi podatki.
The European Food Safety Authority (EFSA) has delivered an opinion on the use of this preparation which concludes that it does not present a risk for this additional animal category.
Evropska agencija za varnost hrane (EFSA) je o uporabi tega pripravka pripravila mnenje, v katerem ugotavlja, da ne predstavlja tveganja za ti dodatni kategoriji živali.
The assessment shows that the conditions laid down in Article 9e(1) of Directive 70/524/EEC for an authorisation of that preparation for that use are satisfied.
Ocena kaže, da so pogoji iz člena 9e(1) Direktive 70/524/EGS za dovoljenje navedenega pripravka za navedeno uporabo izpolnjeni.
Accordingly, the use of that enzyme preparation, as specified in Annex III, should be authorised for four years.
V skladu s tem je treba uporabo navedenega encimskega pripravka, kot je določen v Prilogi III, dovoliti za štiri leta.
The use of the enzyme preparation of endo-1,4-beta-xylanase produced by Trichoderma longibrachiatum (ATCC 2105) and subtilisin produced by Bacillus subtilis (ATCC 2107) was authorised without a time limit for chickens for fattening by Commission Regulation (EC) No 943/2005 [9].
Uporaba encimskega pripravka endo-1,4-beta-ksilanaze, ki jo proizvaja Trichoderma longibrachiatum (ATCC 2105), in subtilizina, ki ga proizvaja Bacillus subtilis (ATCC 2107), je bila z Uredbo Komisije (ES) št. 943/2005 [9] dovoljena brez časovne omejitve za piščance za pitanje.
New data were submitted in support of an application to extend the authorisation of the use of this enzyme preparation to ducks.
V podporo zahtevku za razširitev dovoljenja za uporabo tega encimskega pripravka na race so bili predloženi novi podatki.
The EFSA has delivered an opinion on the use of this preparation which concludes that it does not present a risk for this additional animal category.
EFSA je o uporabi tega pripravka pripravila mnenje, v katerem je ugotovila, da ne predstavlja tveganja za to dodatno kategorijo živali.
The use of the enzyme preparation of endo-1,4-beta-xylanase produced by Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glucanase and alpha-amylase produced by Bacillus amyloliquefaciens (DSM 9553), subtilisin produced by Bacillus subtilis (ATCC 2107) and polygalacturonase produced by Aspergillus aculeatus (CBS 589.94) was provisionally authorised for chickens for fattening by Regulation (EC) No 418/2001.
Uporaba encimskega pripravka endo-1,4-beta-ksilanaze, ki jo proizvaja Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glukanaze in alfa-amilaze, ki ju proizvaja Bacillus amyloliquefaciens (DSM 9553), subtilizina, ki ga proizvaja Bacillus subtilis (ATCC 2107), in poligalakturonaze, ki jo proizvaja Aspergillus aculeatus (CBS 589.94), je bila z Uredbo (ES) št. 418/2001 začasno dovoljena za piščance za pitanje.
New data were submitted in support of two applications to extend the authorisation of the use of this enzyme preparation to ducks and laying hens.
V podporo dvema zahtevkoma za razširitev dovoljenja za uporabo tega encimskega pripravka na race in kokoši nesnice so bili predloženi novi podatki.
The EFSA has delivered an opinion on the use of this preparation on each of the two animal categories which conclude in both cases that it does not present a risk for them.
EFSA je o uporabi tega pripravka pripravila mnenji za obe kategoriji živali, v katerih je ugotovila, da ne predstavlja tveganja za nobeno od njiju.
Accordingly, the use of that enzyme preparation for ducks and laying hens, as specified in Annex III, should be authorised for four years.
V skladu s tem je treba uporabo navedenega encimskega pripravka za race in kokoši nesnice, kot je določen v Prilogi III, dovoliti za štiri leta.
The assessment of these applications shows that certain procedures should be required to protect workers from exposure to the additives set out in the Annexes.
Ocena teh zahtevkov kaže, da so potrebni nekateri postopki za zaščito delavcev pred izpostavljenostjo dodatkom iz prilog.
Such protection should be assured by the application of Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work [10].
Takšno zaščito je treba zagotoviti z uporabo Direktive Sveta 89/391/EGS z dne 12. junija 1989 o uvajanju ukrepov za spodbujanje izboljšav varnosti in zdravja delavcev pri delu [10].
The preparations belonging to the group ‘Micro-organisms’, as specified in Annex I, are authorised for use without a time limit as additives in animal nutrition under the conditions laid down in that Annex.
Pripravki, ki spadajo v skupino „Mikroorganizmi“, kot je določena v Prilogi I, so dovoljeni za uporabo brez časovne omejitve kot dodatki v prehrani živali pod pogoji iz navedene priloge.
The preparations belonging to the group ‘Enzymes’, as specified in Annex II, are authorised for use without a time limit as additives in animal nutrition under the conditions laid down in that Annex.
Pripravki, ki spadajo v skupino „Encimi“, kot je določena v Prilogi II, so dovoljeni za uporabo brez časovne omejitve kot dodatki v prehrani živali pod pogoji iz navedene priloge.
The preparations belonging to the group ‘Enzymes’, as specified in Annex III, are authorised for use for four years as additives in animal nutrition under the conditions laid down in that Annex.
Pripravki, ki spadajo v skupino „Encimi“, kot je določena v Prilogi III, so dovoljeni za uporabo za obdobje štirih let kot dodatki v prehrani živali pod pogoji iz navedene priloge.
2 × 1010 CFU/g additive
Pripravek Saccharomyces cerevisiae z vsebnostjo najmanj: 2 × 1010 CFU/g dodatka
1 × 1010 CFU/g additive
Pripravek Pediococcus acidilactici z vsebnostjo najmanj: 1 × 1010 CFU/g dodatka
1 × 109 CFU/g additive
Pripravek Enterococcus faecium z vsebnostjo najmanj: 1 × 109 CFU/g dodatka
Units of activity/kg of complete feedingstuff
CFU/kg popolne krmne mešanice
Preparation of endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (CBS 526.94) having a minimum activity of:
Pripravek endo-1,3(4)-beta-glukanaze, ki jo proizvaja Trichoderma reesei (CBS 526.94), z najmanjšo aktivnostjo:
Solid form: 700000 BU [1]/g
V trdi obliki: 700000 BU [1]/g
Liquid form: 300000 BU/g
V tekoči obliki: 300000 BU/g
Recommended dose per kg of complete feedingstuff: 17500-50000 BU.
Priporočen odmerek na kg popolne krmne mešanice: 17500–50000 BU.
For use in compound feed rich in non-starch polysaccharides (mainly glucans), e.g. containing more than 20 % barley or 30 % rye.
Za uporabo v krmnih mešanicah, bogatih z neškrobnimi polisaharidi (zlasti glukani), npr. z vsebnostjo več kot 20 % ječmena ali 30 % rži.
Preparation of endo-1,4-beta-xylanase produced by Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glucanase and alpha-amylase produced by Bacillus amyloliquefaciens (DSM 9553), subtilisin produced by Bacillus subtilis (ATCC 2107), polygalacturonase produced by Aspergillus aculeatus (CBS 589.94) having a mimimum activity of:
Pripravek endo-1,4-beta-ksilanaze, ki jo proizvaja Trichoderma longibrachiatum (ATCC 2105), endo-1,3(4)-beta-glukanaze in alfa-amilaze, ki ju proizvaja Bacillus amyloliquefaciens (DSM 9553), subtilizina, ki ga proizvaja Bacillus subtilis (ATCC 2107), poligalakturonaze, ki jo proizvaja Aspergillus aculeatus (CBS 589.94), z najmanjšo aktivnostjo:
Endo-1,4-beta-xylanase: 300 U [2]/g
endo-1,4-beta-ksilanaza: 300 U [2]/g
Endo-1,3(4)-beta-glucanase: 150 U [3]/g
Endo-1,3(4)-beta-glukanaza: 150 U [3]/g
Alpha-amylase: 400 U [5]/g
alfa-amilaza: 400 U [5]/g
Polygalacturonase: 25 U [6]/g
poligalakturonaza: 25 U [6]/g
endo-1,4-beta-xylanase: 300 U
endo-1,4-beta-ksilanaza: 300 U
endo-1,3(4)-beta-glucanase: 150 U
endo-1,3(4)-beta-glukanaza: 150 U
alpha-amylase: 400 U
alfa-amilaza: 400 U
For use in compound feed rich in starch and non-starch polysaccharides (mainly arabinoxylans and beta-glucans), e.g. containing more than 40 % maize or 60 % wheat.
Za uporabo v krmnih mešanicah, bogatih s škrobnimi in neškrobnimi polisaharidi (zlasti arabinoksilani in beta-glukani), npr. z vsebnostjo več kot 40 % koruze ali 60 % pšenice.
endo-1,3(4)-beta-glucanase:
Endo-1,3(4)-beta-Glukanaza:
alpha-amylase:
Alfa-amilaza:
polygalacturonase:
Poligalakturonaza:
1 U is the amount of enzyme which liberates 1 micromole of reducing sugars (xylose equivalents) from oat spelt xylan per minute at pH 5,3 and 50 °C.
1 U je količina encima, ki sprosti 1 mikromol reduktivnih sladkorjev (ekvivalentov ksiloze) iz ksilana ovsenih plev na minuto pri pH 5,3 in 50 °C.
1 U is the amount of enzyme which liberates 1 microgram of phenolic compound (tyrosine equivalents) from a casein substrate per minute at pH 7,5 and 40 °C.
1 U je količina encima, ki sprosti 1 mikrogram fenolne spojine (ekvivalentov tirozina) iz substrata kazeina na minuto pri pH 7,5 in 40 °C.
1 U is the amount of enzyme which hydrolyses 1 micromole of glucosidic linkages from a water insoluble cross-linked starch polymer substrate per minute at pH 6,5 and 37 °C.
1 U je količina encima, ki hidrolizira 1 mikromol glukozidnih vezi iz v vodi netopnega navzkrižno vezanega polimernega substrata iz škroba na minuto pri pH 6,5 in 37 °C.
1 U is the amount of enzyme which liberates 1 micromole of reducing material (galacturonic acid equivalents) from a poly D-galacturonic substrate per minute at pH 5,0 and 40 °C.
1 U je količina encima, ki sprosti 1 mikromol reduktivnega materiala (ekvivalentov galakturonske kisline) iz poli D-galakturonskega substrata na minuto pri pH 5,0 in 40 °C.
Preparation of endo-1,4-beta-xylanase produced by Aspergillus oryzae (DSM 10287) having a minimum activity of:
Pripravek endo-1,4-beta-ksilanaze, ki jo proizvaja Aspergillus oryzae (DSM 10287), z najmanjšo aktivnostjo:
Recommended dose per kg of complete feedingstuff: 200-400 FXU.
Priporočen odmerek na kg popolne krmne mešanice: 200–400 FXU.
For use in compound feed rich in non-starch polysaccharides (mainly arabinoxylans), e.g. containing more than 50 % cereals (e.g. wheat, barley, rye or triticale).
Za uporabo v krmnih mešanicah, bogatih z neškrobnimi polisaharidi (zlasti arabinoksilani), npr. z vsebnostjo več kot 50 % žita (npr. pšenice, ječmena, rži ali tritikale).
Recommended dose per kg of complete feedingstuff: 100-200 FXU.
Priporočen odmerek na kg popolne krmne mešanice: 100–200 FXU.
Preparation of endo-1,4-beta-xylanase produced by Trichoderma longibrachiatum (ATCC 2105) and subtilisin produced by Bacillus subtilis (ATCC 2107) having a minimum activity of:
Pripravek endo-1,4-beta-ksilanaze, ki jo proizvaja Trichoderma longibrachiatum (ATCC 2105), in subtilizina, ki ga proizvaja Bacillus subtilis (ATCC 2107), z najmanjšo aktivnostjo:
Endo-1,4-beta-xylanase: 5000 U [2]/g
endo-1,4-beta-ksilanaza: 5000 U [2]/g
endo-1,4-beta-xylanase: 2500 U
endo-1,4-beta-ksilanaza: 2500 U
For use in compound feed e.g. containing more than 65 % wheat.
Za uporabo v krmnih mešanicah npr. z vsebnostjo več kot 65 % pšenice.
Endo-1,3(4)-beta-glucanase: 150 U [4]/g
endo-1,3(4)-beta-glukanaza: 150 U [4]/g
For use in compound feed rich in starch and non-starch polysaccharides (mainly arabinoxylans and beta-glucans), e.g. containing more than 40 % maize.
Za uporabo v krmnih mešanicah, bogatih s škrobnimi in neškrobnimi polisaharidi (zlasti arabinoksilani in beta-glukani), npr. z vsebnostjo več kot 40 % koruze.
endo-1,4-beta-xylanase: 225 U
endo-1,4-beta-ksilanaza: 225 U
endo-1,3(4)-beta-glucanase: 112 U
endo-1,3(4)-beta-glukanaza: 112 U
alpha-amylase: 300 U
alfa-amilaza: 300 U
polygalacturonase: 18 U.
poligalakturonaza: 18 U.
polygalac-turonase:
Poligalakturonaza:
subtilisin: 800 U.
subtilizin: 800 U.
Subtilisin: 4000 U [4]/g
Subtilizin: 4000 U [4]/g
subtilisin: 4000 U
subtilizin: 4000 U
Subtilisin: 1600 U [3]/g
subtilizin: 1600 U [3]/g
Subtilisin: 4000 U [3]/g
subtilizin: 4000 U [3]/g
subtilisin: 3000 U
subtilizin: 3000 U
Commission Regulation (EC) No 2037/2005
Uredba Komisije (ES) št. 2037/2005
amending the conditions for authorisation of a feed additive belonging to the group of coccidiostats
o spremembi pogojev za dovoljenje za krmni dodatek, ki sodi v skupino kokcidiostatikov
Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition [1] and in particular Article 13(3) thereof,
ob upoštevanju Uredbe (ES) št. 1831/2003 Evropskega parlamenta in Sveta z dne 22. septembra 2003 o dodatkih za uporabo v prehrani živali [1], in zlasti člena 13(3) Uredbe,
The additive lasalocid A sodium (Avatec 15 %) was authorised under certain conditions in accordance with Council Directive 70/524/EEC [2].
V skladu z Direktivo Sveta 70/524/EGS [2] se dodatek lasalocid A natrij (Avatec 15 %) dovoli pod določenimi pogoji.
This additive is currently authorised in the group ‘coccidiostats’ for turkeys by Commission Regulation (EC) No 2430/1999 [3] and chickens reared for laying and chickens for fattening by Commission Regulation (EC) No 1455/2004 [4].
Ta dodatek je trenutno z Uredbo Komisije (ES) št. 2430/1999 [3] dovoljen v skupini „kokcidiostatiki“ za purane in z Uredbo Komisije (ES) št. 1455/2004 [4] za rejene nesnice ter za pitanje piščancev.
This additive has been notified as existing product on the basis of Article 10 of Regulation (EC) No 1831/2003 and is subject to the verifications and the procedures in application of that provision.
Ta dodatek je priglašen na podlagi člena 10 Uredbe (ES) št. 1831/2003 kot obstoječi proizvod in je predmet preverjanja in postopkov v skladu z navedeno določbo.
The company concerned submitted a new supplementary dossier requesting a modification of existing carrier.
Zadevno podjetje predloži novo dopolnilno dokumentacijo s prošnjo za spremembo obstoječe nosilne snovi.
Regulation (EC) No 1831/2003 provides for the possibility to modify the authorisation of an additive further to an opinion of the European Food Safety Authority (the Authority) on whether the authorisation still meets the conditions set out in that Regulation.
Uredba (ES) št. 1831/2003 predvideva možnost spremembe dovoljenja za dodatek v skladu z mnenjem Evropske agencije za varno hrano („Agencija“) glede vprašanja, ali dovoljenje še ustreza pogojem iz navedene uredbe.
The Commission asked the Authority to evaluate the relevant data supporting the application for the change of authorisation referred to in Regulations (EC) Nos 2430/1999 and 1455/2004 and to advise on the possible harmful effects on safety and efficacy when lasalocid A sodium is used by new carrier.
Komisija je zaprosila Agencijo, da oceni ustrezne podatke, ki spremljajo vlogo za spremembo dovoljenja v skladu z uredbama (ES) št. 2430/1999 in 1455/2004 ter opozori na možne škodljive učinke na varnost in učinkovitost lasalocida A natrija, kadar se ta uporablja z novo nosilno snovjo.
Following this request, the Authority has published on 26 August 2005 an opinion on the use of lasalocid A sodium in feedingstuffs.
Na to zahtevo je Agencija 26. avgusta 2005 objavila mnenje o uporabi lasalocida A natrija v krmi.
The opinion of the Authority concludes that the use of the new formulation would not be expected to introduce any additional risks or concerns for human, animal and environmental safety and that the new formulation does not adversely influence the stability of lasalocid A sodium.
V mnenju Agencija ugotavlja, da uporaba nove formulacije ne bi povzročila dodatnega tveganja ali skrbi za varnost ljudi, živali ter okolja in da nova formulacija ne more škodljivo vplivati na stabilnost lasalocida A natrija.
A Maximum Residue Level (MRL) for substance concerned has been established by Council Regulation (EEC) No 2377/90 of 26 June 1990 [5] laying down a Community procedure for the establishment of maximum residue levels of veterinary medicinal products in foodstuffs of animal origin.
Mejne vrednosti ostankov (MVO) za navedeno snov določa Uredba Sveta (EGS) št. 2377/90 z dne 26. junija 1990 [5] o določitvi postopka Skupnosti za določanje najvišjih mejnih vrednosti ostankov zdravil za uporabo v veterinarski medicini v živilih živalskega izvora.
Regulations (EC) Nos 2430/1999 and 1455/2004 should therefore be amended accordingly.
Uredbi (ES) št. 2430/1999 in 1455/2004 je zato treba ustrezno spremeniti.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health.
Ukrepi, predvideni s to uredbo, so v skladu z mnenjem Stalnega odbora za prehranjevalno verigo in zdravje živali –
In Annex I to Regulation (EC) No 2430/1999, the entry relating to E 763, lasalocid A sodium, is replaced by the text in Annex I to this Regulation.
V Prilogi I k Uredbi (ES) št. 2430/1999 se vnos, ki se nanaša na E 763, lasalocid A natrij, nadomesti z besedilom iz Priloge I k tej uredbi.
The Annex to Regulation (EC) No 1455/2004 is replaced by Annex II to this Regulation.
Priloga k Uredbi (ES) št. 1455/2004 se nadomesti s Prilogo II k tej uredbi.
OJ L 296, 17.11.1999, p. 3.
UL L 296, 17.11.1999, str. 3.
Regulation as amended by Commission Regulation (EC) No 712/2005 (OJ L 120, 12.5.2005, p. 3).
Uredba, kakor je bila spremenjena z Uredbo Komisije (ES) št. 712/2005 (UL L 120, 12.5.2005, str. 3).
Name and registration number of person responsible for putting additive into circulation
Ime in registracijska številka osebe, odgovorne za dajanje dodatka v obtok
(Trade name)
(trgovsko ime)
Maximum Residue Limits
Največji preostanek mejne vrednosti
(MRLs)
(MVO)
Coccidiostats and histomonostats
Kokcidiostatiki in histomonostatiki
Lasalocid A sodium 15 g/100 g
Lasalocid A natrij: 15 g/100 g
Lasalocid A sodium: 15 g/100 g
Lasalocid A natrij: 15 g/100 g
Corn cob meal: 80,95 g/100 g
Moka iz koruznih storžev: 80,95 g/100 g